Global Stroke Diagnostics Market – Industry Trends and Forecast to 2031

Stroke Diagnostics Market Analysis and Size

Stroke diagnostics play a pivotal role in identifying and assessing cerebrovascular events accurately. Utilizing imaging techniques such as MRI and CT scans, along with clinical assessments, these diagnostics aid in determining the type, severity, and location of strokes, guiding timely and tailored treatment strategies for optimal patient outcomes.                            

Data Bridge Market Research analyses that the global stroke diagnostics market, which was USD 3,839.94 million in 2023, is expected to reach USD 6,548.57 million by 2031, and is expected to undergo a CAGR of 6.9% during the forecast period of 2024 to 2031. This indicates that the market value. “Computed tomography (CT scan)” is expected to dominate the type segment of the stroke diagnostics market owing to the continuous enhancement in CT scan technology contributes to its dominance, offering healthcare professionals accurate and detailed insights in stroke diagnosis, thereby influencing the market's growth. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Stroke Diagnostics Market Scope and Segmentation

Market Definition

Stroke diagnostics involves various techniques to identify and assess strokes, a medical emergency characterized by disrupted blood flow to the brain. Diagnostic methods include imaging studies such as CT scans and MRIs, blood tests, and neurological examinations. Early and accurate diagnosis is critical for prompt intervention and effective management of stroke patients.

Global Stroke Diagnostics Market Dynamics

Drivers

• Integration of AI and ML into Diagnostic Tools

The integration of AI and machine learning into diagnostic tools propels the stroke diagnostics market. Through enabling sophisticated and rapid analysis, these technologies enhance the accuracy and efficiency of stroke diagnostics, providing healthcare professionals with advanced insights, improving patient outcomes, and driving the market's growth.

• Rising Incidence of Strokes in Aging Population

The growing aging population significantly fuels the stroke diagnostics market, correlating with an elevated incidence of strokes among the elderly. This demographic trend emphasizes the increasing need for advanced diagnostic tools and services to address the higher vulnerability of the aging population to stroke-related health challenges.

Opportunities

• Growing Healthcare Expenditure in  Developed Regions

Higher healthcare spending in developed regions enables broader accessibility to advanced diagnostic services, fueling market growth for stroke diagnostics. With increased financial resources allocated to healthcare, patients have greater access to state-of-the-art diagnostic technologies, enhancing early detection and treatment of cerebrovascular events such as strokes.

• Personalized Medicine in Stroke Diagnostics

Advancements in personalized medicine revolutionize stroke diagnostics, enabling customized approaches. Tailored diagnostic strategies consider an individual's unique genetic and molecular characteristics, enhancing the precision of stroke detection and management. This personalized approach optimizes treatment plans, fostering more effective interventions and improving outcomes for patients with strokes. 

Restraints/Challenges

• High Cost of Diagnostic Imaging Technologies

The high cost of advanced diagnostic imaging technologies, notably MRI and CT scans, acts as a significant impediment to the widespread adoption of stroke diagnostics. This financial barrier, particularly in resource-limited healthcare settings, restricts accessibility and hampers the market's potential for broader utilization and improved patient outcomes. 

• Risk of Radiation Exposure in Imaging Technologies

The risk of radiation exposure, notably in repeated CT scans, poses a challenge for the stroke diagnostics market. Concerns about potential harm may lead to hesitancy among healthcare providers and patients, influencing the frequency of use of diagnostic imaging technologies and potentially impacting timely stroke diagnosis and treatment decisions.

This global stroke diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global stroke diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2021, Siemens launched the Somatom X.ceed, a high-resolution, high-speed CT scanner designed for challenging clinical areas. This innovation enhances Siemens' product pipeline, delivering their commitment to advancing diagnostic imaging technologies. The Somatom X.ceed is tailored to deliver precise and efficient imaging, catering to the complex demands of diverse clinical scenarios
• In April 2021, the FDA authorized the Neurolutions IpsiHand Upper Extremity Rehabilitation System by Neurolutions, Inc. This Brain-Computer-Interface (BCI) device facilitates rehabilitation for stroke patients with upper extremity disabilities, specifically addressing hand, wrist, and arm impairments. The approval underscores its potential in enhancing neurorehabilitation outcomes for individuals recovering from stroke-related motor deficits
• In April 2021, Koninklijke Philips N.V. announced a strategic partnership with Ibex Medical Analytics to collectively advance their digital pathology and A.I. solutions globally. This collaboration aims to strengthen their distribution channels, facilitating enhanced accessibility to innovative pathology solutions for hospitals, health networks, and pathology labs worldwide
• In September 2020, Hyperfine Research, Inc. obtained FDA 510(k) clearance for their groundbreaking Swoop Portable MR imaging device. This portable MRI technology redefines point-of-care imaging, allowing for on-the-spot magnetic resonance imaging. The FDA clearance signifies a significant advancement, enabling more accessible and immediate diagnostic imaging in diverse healthcare settings
• In June 2020, RapidAI achieved FDA clearance for artificial intelligence algorithms capable of swiftly analyzing brain CT scans, identifying suspected large vessel occlusions—a leading cause of severe strokes. Additionally, they obtained FDA clearance for computer-assisted diagnostic software, enhancing physicians' interpretation of non-contrast CT scans, reflecting advancements in stroke diagnostics technology

Global Stroke Diagnostics Market Scope

The global stroke diagnostics market is segmented on the basis of severity, type, technology, application, end user, distribution channel, and stage. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Severity

• Moderate
• Severe
• Mild

Type

• Diagnostics
• Therapeutics
• Tissue Plasminogen Activator
•  Antiplatelet
• Antihypertensive
•  Anticoagulant
• Software

 Technology

• Computed Tomography (CT Scan)
• Computed Tomography Angiography (CTA)
• Magnetic Resonance Imaging (MRI)
• Magnetic Resonance Angiography (MRA)
• Transcranial Doppler Ultrasound
• Video Head Impulse Test (VHIT)
• Electrocardiography
• Carotid Ultrasound
• Cerebral Angiography
• Others

 Application

• Ischemic Stroke
• Hemorrhagic Stroke
• Transient Ischemic Attacks (TIAS)

 End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Home Healthcare

 Distribution Channel

• Direct Tender
• Third Party Distributors
• Others

Stage

• Pre Operative
• Peri Operative
• Post Operative

Global Stroke Diagnostics Market Regional Analysis/Insights

The global stroke diagnostics market is analysed and market size insights and trends are provided by country, severity, type, technology, application, end user, distribution channel, and stage as referenced above.

The countries covered in the global stroke diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global stroke diagnostics market, propelled by the largest consumer market and a high GDP. The U.S., in particular, is poised to lead with advancements in technology and a rising incidence of strokes. This region's economic strength and healthcare innovation contribute significantly to its prominence in stroke diagnostics.

Europe is expected to dominate the global stroke diagnostics market, with Germany emerging as a key contributor to promising growth rates forecasted from 2024 to 2031. This upsurge is attributed to heightened research and development endeavors, positioning the region as a frontrunner in advancing stroke diagnostic technologies and practices.

Asia-Pacific is expected to dominate the global stroke diagnostics market from 2024 to 2031, driven by leading countries such as Japan. With a surge in product usage and advancements in product development, Japan is anticipated to take the lead, emphasizing the region's pivotal role in shaping the landscape of stroke diagnostics worldwide.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global stroke diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global stroke diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global stroke diagnostics market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Stroke Diagnostics Market Share Analysis

The global stroke diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global stroke diagnostics market.

Some of the major players operating in the global stroke diagnostics market are:

• Siemens Healthcare GmbH  (Germany)
• Koninklijke Philips N.V. (Netherlands)
•  GE HealthCare.  (U.S.)
•  Mindray Medical India Pvt. Ltd.  (India)
•  FUJIFILM Corporation (Japan)
•  CANON MEDICAL SYSTEMS CORPORATION (Japan)
•   ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea)
•  Analogic Corporation (U.S.)
•  Aspect Imaging Ltd.  (U.S.)
•  BPL Medical Technologies (India)
•  Carestream Health. (U.S.)
•  Esaote S.p.A (Italy)
•  FONAR Corp. (U.S.)
•  Hologic, Inc.  (U.S.)
•  IMRIS Inc. (Canada)
•  Medfield Diagnostics AB. (Sweden)
•  MEDTRON AG (Germany)  

SKU-40260